First Trust Advisors LP decreased its position in Clorox Co (NYSE:CLX) by 11.4% during the 4th quarter, Holdings Channel reports. The fund owned 178,910 shares of the company’s stock after selling 22,973 shares during the quarter. First Trust Advisors LP’s holdings in Clorox were worth $26,611,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its holdings in Clorox by 63.2% in the third quarter. JPMorgan Chase & Co. now owns 417,347 shares of the company’s stock valued at $54,269,000 after acquiring an additional 161,555 shares during the last quarter. Vident Investment Advisory LLC bought a new position in Clorox in the third quarter valued at about $1,477,000. Allianz Asset Management GmbH boosted its holdings in Clorox by 417.8% in the third quarter. Allianz Asset Management GmbH now owns 63,868 shares of the company’s stock valued at $8,425,000 after acquiring an additional 51,534 shares during the last quarter. Jensen Investment Management Inc. boosted its holdings in Clorox by 12.1% in the fourth quarter. Jensen Investment Management Inc. now owns 40,960 shares of the company’s stock valued at $6,092,000 after acquiring an additional 4,435 shares during the last quarter. Finally, Spearhead Capital Advisors LLC bought a new position in Clorox in the fourth quarter valued at about $2,846,000. Institutional investors and hedge funds own 74.11% of the company’s stock.
In other news, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.00% of the company’s stock.
Clorox Co (NYSE CLX) opened at $127.30 on Friday. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.35. Clorox Co has a 1-year low of $124.09 and a 1-year high of $150.40. The stock has a market capitalization of $16,470.00, a PE ratio of 21.15, a price-to-earnings-growth ratio of 2.37 and a beta of 0.31.
Clorox (NYSE:CLX) last issued its earnings results on Friday, February 2nd. The company reported $1.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.22 by $0.01. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter last year, the business earned $1.14 earnings per share. The company’s revenue was up .7% compared to the same quarter last year. sell-side analysts expect that Clorox Co will post 6.23 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Stockholders of record on Wednesday, April 25th will be issued a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a dividend yield of 3.02%. The ex-dividend date of this dividend is Tuesday, April 24th. This is a boost from Clorox’s previous quarterly dividend of $0.84. Clorox’s payout ratio is 55.81%.
CLX has been the topic of several recent research reports. Deutsche Bank initiated coverage on Clorox in a report on Wednesday, December 13th. They issued a “hold” rating and a $142.00 price target on the stock. Wells Fargo & Co reiterated a “hold” rating and issued a $130.00 price target on shares of Clorox in a report on Wednesday, December 13th. Zacks Investment Research cut Clorox from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. Consumer Edge upgraded Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Finally, Morgan Stanley decreased their price target on Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a report on Thursday, November 2nd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $132.46.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thelincolnianonline.com/2018/02/23/first-trust-advisors-lp-sells-22973-shares-of-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.